3 transcripts
KRMD
Earnings call transcript
NASDAQ
2024 Q2
7 Aug 24
want to take a few moments to dive deeper into the U.S. SCIg market, our largest market, where we hold a leadership position and discuss what we see
KRMD
Earnings call transcript
NASDAQ
2023 Q4
13 Mar 24
. As it relates to our Domestic Core, our goal is to increase penetration into the SCIg market and further establish our leadership position.
With respect
KRMD
Earnings call transcript
NASDAQ
2023 Q2
9 Aug 23
and our 3 growth drivers. Starting with the first, growing our leadership position in SCIg. Today, KORU has over 35,000 patients in the U.S. and strong
- Prev
- 1
- Next